Hangzhou Coco Healthcare Products Co.Ltd. (301009) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a cash flow conversion efficiency ratio of -0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.53 Million ≈ $-2.56 Million USD) by net assets (CN¥1.41 Billion ≈ $206.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Hangzhou Coco Healthcare Products Co.Ltd to measure how much of total assets are equity-financed.
Hangzhou Coco Healthcare Products Co.Ltd. - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hangzhou Coco Healthcare Products Co.Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Hangzhou Coco Healthcare Products Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hangzhou Coco Healthcare Products Co.Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
INVALDA INVL AB EO-29
F:WTK
|
N/A |
|
Hollyland China Electronics Technology Corp Ltd
SHE:002729
|
0.036x |
|
DINE S.A.B. de C.V
MX:DINEB
|
-0.024x |
|
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
|
0.027x |
|
Integra Resources Corp
V:ITR
|
0.262x |
|
Emeco Holdings Ltd
AU:EHL
|
0.189x |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
-0.022x |
|
Yarward Electronics Shandong Co. Ltd. A
SHE:301337
|
N/A |
Annual Cash Flow Conversion Efficiency for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below shows the annual cash flow conversion efficiency of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 301009 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.41 Billion ≈ $206.55 Million |
CN¥52.44 Million ≈ $7.67 Million |
0.037x | -76.35% |
| 2023-12-31 | CN¥1.45 Billion ≈ $212.12 Million |
CN¥227.70 Million ≈ $33.32 Million |
0.157x | +704.51% |
| 2022-12-31 | CN¥1.43 Billion ≈ $209.51 Million |
CN¥-37.20 Million ≈ $-5.44 Million |
-0.026x | -177.51% |
| 2021-12-31 | CN¥1.51 Billion ≈ $220.53 Million |
CN¥50.53 Million ≈ $7.39 Million |
0.034x | -94.23% |
| 2020-12-31 | CN¥681.55 Million ≈ $99.73 Million |
CN¥395.86 Million ≈ $57.93 Million |
0.581x | +19.13% |
| 2019-12-31 | CN¥458.05 Million ≈ $67.03 Million |
CN¥223.33 Million ≈ $32.68 Million |
0.488x | +128.56% |
| 2018-12-31 | CN¥535.64 Million ≈ $78.38 Million |
CN¥114.26 Million ≈ $16.72 Million |
0.213x | -8.14% |
| 2017-12-31 | CN¥472.55 Million ≈ $69.15 Million |
CN¥109.74 Million ≈ $16.06 Million |
0.232x | -- |
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more